nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—CYP1A2—chronic obstructive pulmonary disease	0.398	1	CbGaD
Ofloxacin—SLC22A4—Tiotropium—chronic obstructive pulmonary disease	0.232	0.581	CbGbCtD
Ofloxacin—SLC22A5—Tiotropium—chronic obstructive pulmonary disease	0.131	0.328	CbGbCtD
Ofloxacin—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0363	0.0909	CbGbCtD
Ofloxacin—TOP2A—Salmeterol—Salbutamol—chronic obstructive pulmonary disease	0.00177	0.807	CbGdCrCtD
Ofloxacin—Pefloxacin—CYP1A2—chronic obstructive pulmonary disease	0.00073	0.179	CrCbGaD
Ofloxacin—Enoxacin—CYP1A2—chronic obstructive pulmonary disease	0.000683	0.167	CrCbGaD
Ofloxacin—Gatifloxacin—ALB—chronic obstructive pulmonary disease	0.000556	0.136	CrCbGaD
Ofloxacin—Lomefloxacin—CYP1A2—chronic obstructive pulmonary disease	0.000518	0.127	CrCbGaD
Ofloxacin—Levofloxacin—CYP1A2—chronic obstructive pulmonary disease	0.000442	0.108	CrCbGaD
Ofloxacin—Ciprofloxacin—CYP1A2—chronic obstructive pulmonary disease	0.000427	0.105	CrCbGaD
Ofloxacin—Norfloxacin—CYP1A1—chronic obstructive pulmonary disease	0.000372	0.091	CrCbGaD
Ofloxacin—Norfloxacin—CYP1A2—chronic obstructive pulmonary disease	0.000359	0.0878	CrCbGaD
Ofloxacin—TOP2A—Methyltestosterone—Prednisone—chronic obstructive pulmonary disease	0.000213	0.0975	CbGdCrCtD
Ofloxacin—TOP2A—Methyltestosterone—Prednisolone—chronic obstructive pulmonary disease	0.000208	0.0952	CbGdCrCtD
Ofloxacin—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000588	CcSEcCtD
Ofloxacin—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000587	CcSEcCtD
Ofloxacin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000114	0.000583	CcSEcCtD
Ofloxacin—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000581	CcSEcCtD
Ofloxacin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.000579	CcSEcCtD
Ofloxacin—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.000579	CcSEcCtD
Ofloxacin—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.000575	CcSEcCtD
Ofloxacin—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.000573	CcSEcCtD
Ofloxacin—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000112	0.000573	CcSEcCtD
Ofloxacin—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000573	CcSEcCtD
Ofloxacin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000112	0.00057	CcSEcCtD
Ofloxacin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.00057	CcSEcCtD
Ofloxacin—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000569	CcSEcCtD
Ofloxacin—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.000568	CcSEcCtD
Ofloxacin—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000567	CcSEcCtD
Ofloxacin—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.000565	CcSEcCtD
Ofloxacin—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000565	CcSEcCtD
Ofloxacin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000562	CcSEcCtD
Ofloxacin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00011	0.00056	CcSEcCtD
Ofloxacin—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.00056	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00011	0.000559	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00011	0.000559	CcSEcCtD
Ofloxacin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000109	0.000555	CcSEcCtD
Ofloxacin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000109	0.000555	CcSEcCtD
Ofloxacin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.000552	CcSEcCtD
Ofloxacin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000108	0.000551	CcSEcCtD
Ofloxacin—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000549	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000107	0.000547	CcSEcCtD
Ofloxacin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.000547	CcSEcCtD
Ofloxacin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000107	0.000547	CcSEcCtD
Ofloxacin—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.000545	CcSEcCtD
Ofloxacin—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000107	0.000545	CcSEcCtD
Ofloxacin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000107	0.000543	CcSEcCtD
Ofloxacin—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000541	CcSEcCtD
Ofloxacin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000106	0.00054	CcSEcCtD
Ofloxacin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000106	0.00054	CcSEcCtD
Ofloxacin—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000106	0.000539	CcSEcCtD
Ofloxacin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000105	0.000538	CcSEcCtD
Ofloxacin—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000105	0.000534	CcSEcCtD
Ofloxacin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000105	0.000533	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000104	0.000529	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000104	0.000529	CcSEcCtD
Ofloxacin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000104	0.000529	CcSEcCtD
Ofloxacin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000104	0.000529	CcSEcCtD
Ofloxacin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000104	0.000529	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.000528	CcSEcCtD
Ofloxacin—Pain—Formoterol—chronic obstructive pulmonary disease	0.000103	0.000524	CcSEcCtD
Ofloxacin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.000524	CcSEcCtD
Ofloxacin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000103	0.000524	CcSEcCtD
Ofloxacin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.000524	CcSEcCtD
Ofloxacin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.000524	CcSEcCtD
Ofloxacin—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000523	CcSEcCtD
Ofloxacin—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.00052	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000102	0.000519	CcSEcCtD
Ofloxacin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000102	0.000518	CcSEcCtD
Ofloxacin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.000516	CcSEcCtD
Ofloxacin—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.000515	CcSEcCtD
Ofloxacin—Pain—Montelukast—chronic obstructive pulmonary disease	0.000101	0.000514	CcSEcCtD
Ofloxacin—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.000513	CcSEcCtD
Ofloxacin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.0001	0.000512	CcSEcCtD
Ofloxacin—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.0001	0.00051	CcSEcCtD
Ofloxacin—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.0001	0.00051	CcSEcCtD
Ofloxacin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.0001	0.00051	CcSEcCtD
Ofloxacin—Purpura—Prednisone—chronic obstructive pulmonary disease	9.99e-05	0.000509	CcSEcCtD
Ofloxacin—Rash—Aminophylline—chronic obstructive pulmonary disease	9.97e-05	0.000508	CcSEcCtD
Ofloxacin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	9.96e-05	0.000508	CcSEcCtD
Ofloxacin—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	9.93e-05	0.000506	CcSEcCtD
Ofloxacin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	9.91e-05	0.000505	CcSEcCtD
Ofloxacin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	9.91e-05	0.000505	CcSEcCtD
Ofloxacin—Headache—Aminophylline—chronic obstructive pulmonary disease	9.9e-05	0.000505	CcSEcCtD
Ofloxacin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	9.87e-05	0.000503	CcSEcCtD
Ofloxacin—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	9.87e-05	0.000503	CcSEcCtD
Ofloxacin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	9.86e-05	0.000503	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	9.84e-05	0.000501	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	9.84e-05	0.000501	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	9.81e-05	0.0005	CcSEcCtD
Ofloxacin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	9.79e-05	0.000499	CcSEcCtD
Ofloxacin—Pain—Salbutamol—chronic obstructive pulmonary disease	9.71e-05	0.000495	CcSEcCtD
Ofloxacin—Constipation—Salbutamol—chronic obstructive pulmonary disease	9.71e-05	0.000495	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	9.64e-05	0.000491	CcSEcCtD
Ofloxacin—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	9.63e-05	0.000491	CcSEcCtD
Ofloxacin—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	9.63e-05	0.000491	CcSEcCtD
Ofloxacin—Urticaria—Formoterol—chronic obstructive pulmonary disease	9.56e-05	0.000487	CcSEcCtD
Ofloxacin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	9.56e-05	0.000487	CcSEcCtD
Ofloxacin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	9.51e-05	0.000485	CcSEcCtD
Ofloxacin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	9.51e-05	0.000485	CcSEcCtD
Ofloxacin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	9.51e-05	0.000485	CcSEcCtD
Ofloxacin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	9.51e-05	0.000485	CcSEcCtD
Ofloxacin—Affect lability—Prednisone—chronic obstructive pulmonary disease	9.48e-05	0.000483	CcSEcCtD
Ofloxacin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	9.48e-05	0.000483	CcSEcCtD
Ofloxacin—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	9.41e-05	0.00048	CcSEcCtD
Ofloxacin—Rash—Tiotropium—chronic obstructive pulmonary disease	9.4e-05	0.000479	CcSEcCtD
Ofloxacin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	9.39e-05	0.000479	CcSEcCtD
Ofloxacin—Nausea—Aminophylline—chronic obstructive pulmonary disease	9.39e-05	0.000479	CcSEcCtD
Ofloxacin—Urticaria—Montelukast—chronic obstructive pulmonary disease	9.36e-05	0.000477	CcSEcCtD
Ofloxacin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	9.36e-05	0.000477	CcSEcCtD
Ofloxacin—Headache—Tiotropium—chronic obstructive pulmonary disease	9.34e-05	0.000476	CcSEcCtD
Ofloxacin—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	9.34e-05	0.000476	CcSEcCtD
Ofloxacin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	9.31e-05	0.000475	CcSEcCtD
Ofloxacin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	9.31e-05	0.000475	CcSEcCtD
Ofloxacin—Face oedema—Prednisone—chronic obstructive pulmonary disease	9.3e-05	0.000474	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	9.29e-05	0.000474	CcSEcCtD
Ofloxacin—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	9.22e-05	0.00047	CcSEcCtD
Ofloxacin—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	9.17e-05	0.000467	CcSEcCtD
Ofloxacin—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	9.16e-05	0.000467	CcSEcCtD
Ofloxacin—Mood swings—Prednisone—chronic obstructive pulmonary disease	9.12e-05	0.000465	CcSEcCtD
Ofloxacin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	9.02e-05	0.00046	CcSEcCtD
Ofloxacin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	8.98e-05	0.000458	CcSEcCtD
Ofloxacin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	8.98e-05	0.000458	CcSEcCtD
Ofloxacin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	8.86e-05	0.000452	CcSEcCtD
Ofloxacin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	8.86e-05	0.000452	CcSEcCtD
Ofloxacin—Nausea—Tiotropium—chronic obstructive pulmonary disease	8.85e-05	0.000451	CcSEcCtD
Ofloxacin—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	8.84e-05	0.000451	CcSEcCtD
Ofloxacin—Dry skin—Prednisone—chronic obstructive pulmonary disease	8.83e-05	0.00045	CcSEcCtD
Ofloxacin—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	8.77e-05	0.000447	CcSEcCtD
Ofloxacin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	8.68e-05	0.000443	CcSEcCtD
Ofloxacin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	8.63e-05	0.00044	CcSEcCtD
Ofloxacin—Asthenia—Formoterol—chronic obstructive pulmonary disease	8.63e-05	0.00044	CcSEcCtD
Ofloxacin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	8.51e-05	0.000434	CcSEcCtD
Ofloxacin—Pruritus—Formoterol—chronic obstructive pulmonary disease	8.51e-05	0.000434	CcSEcCtD
Ofloxacin—Asthenia—Montelukast—chronic obstructive pulmonary disease	8.45e-05	0.000431	CcSEcCtD
Ofloxacin—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	8.38e-05	0.000427	CcSEcCtD
Ofloxacin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	8.37e-05	0.000427	CcSEcCtD
Ofloxacin—Pruritus—Montelukast—chronic obstructive pulmonary disease	8.34e-05	0.000425	CcSEcCtD
Ofloxacin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	8.23e-05	0.00042	CcSEcCtD
Ofloxacin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	8.23e-05	0.00042	CcSEcCtD
Ofloxacin—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	8.19e-05	0.000418	CcSEcCtD
Ofloxacin—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	8.16e-05	0.000416	CcSEcCtD
Ofloxacin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	8.15e-05	0.000415	CcSEcCtD
Ofloxacin—Sweating increased—Prednisone—chronic obstructive pulmonary disease	8.11e-05	0.000413	CcSEcCtD
Ofloxacin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	8.06e-05	0.000411	CcSEcCtD
Ofloxacin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	8.04e-05	0.00041	CcSEcCtD
Ofloxacin—Erythema—Prednisolone—chronic obstructive pulmonary disease	7.98e-05	0.000407	CcSEcCtD
Ofloxacin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	7.96e-05	0.000406	CcSEcCtD
Ofloxacin—Dizziness—Formoterol—chronic obstructive pulmonary disease	7.96e-05	0.000406	CcSEcCtD
Ofloxacin—Dizziness—Montelukast—chronic obstructive pulmonary disease	7.79e-05	0.000397	CcSEcCtD
Ofloxacin—Neutropenia—Prednisone—chronic obstructive pulmonary disease	7.78e-05	0.000397	CcSEcCtD
Ofloxacin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	7.77e-05	0.000396	CcSEcCtD
Ofloxacin—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	7.67e-05	0.000391	CcSEcCtD
Ofloxacin—Vomiting—Formoterol—chronic obstructive pulmonary disease	7.65e-05	0.00039	CcSEcCtD
Ofloxacin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	7.65e-05	0.00039	CcSEcCtD
Ofloxacin—Rash—Formoterol—chronic obstructive pulmonary disease	7.59e-05	0.000387	CcSEcCtD
Ofloxacin—Rash—Arformoterol—chronic obstructive pulmonary disease	7.59e-05	0.000387	CcSEcCtD
Ofloxacin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	7.58e-05	0.000386	CcSEcCtD
Ofloxacin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	7.58e-05	0.000386	CcSEcCtD
Ofloxacin—Headache—Arformoterol—chronic obstructive pulmonary disease	7.54e-05	0.000384	CcSEcCtD
Ofloxacin—Headache—Formoterol—chronic obstructive pulmonary disease	7.54e-05	0.000384	CcSEcCtD
Ofloxacin—Weight decreased—Prednisone—chronic obstructive pulmonary disease	7.53e-05	0.000384	CcSEcCtD
Ofloxacin—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	7.52e-05	0.000384	CcSEcCtD
Ofloxacin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	7.51e-05	0.000383	CcSEcCtD
Ofloxacin—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	7.51e-05	0.000383	CcSEcCtD
Ofloxacin—Vomiting—Montelukast—chronic obstructive pulmonary disease	7.49e-05	0.000382	CcSEcCtD
Ofloxacin—Rash—Montelukast—chronic obstructive pulmonary disease	7.43e-05	0.000379	CcSEcCtD
Ofloxacin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	7.42e-05	0.000378	CcSEcCtD
Ofloxacin—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	7.41e-05	0.000378	CcSEcCtD
Ofloxacin—Headache—Montelukast—chronic obstructive pulmonary disease	7.38e-05	0.000376	CcSEcCtD
Ofloxacin—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	7.32e-05	0.000373	CcSEcCtD
Ofloxacin—Angioedema—Prednisolone—chronic obstructive pulmonary disease	7.29e-05	0.000372	CcSEcCtD
Ofloxacin—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	7.28e-05	0.000371	CcSEcCtD
Ofloxacin—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	7.28e-05	0.000371	CcSEcCtD
Ofloxacin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	7.22e-05	0.000368	CcSEcCtD
Ofloxacin—Malaise—Prednisolone—chronic obstructive pulmonary disease	7.2e-05	0.000367	CcSEcCtD
Ofloxacin—Vertigo—Prednisolone—chronic obstructive pulmonary disease	7.17e-05	0.000366	CcSEcCtD
Ofloxacin—Rash—Salbutamol—chronic obstructive pulmonary disease	7.16e-05	0.000365	CcSEcCtD
Ofloxacin—Syncope—Prednisolone—chronic obstructive pulmonary disease	7.16e-05	0.000365	CcSEcCtD
Ofloxacin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	7.16e-05	0.000365	CcSEcCtD
Ofloxacin—Nausea—Formoterol—chronic obstructive pulmonary disease	7.15e-05	0.000364	CcSEcCtD
Ofloxacin—Nausea—Arformoterol—chronic obstructive pulmonary disease	7.15e-05	0.000364	CcSEcCtD
Ofloxacin—Headache—Salbutamol—chronic obstructive pulmonary disease	7.12e-05	0.000363	CcSEcCtD
Ofloxacin—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	7.02e-05	0.000358	CcSEcCtD
Ofloxacin—Nausea—Montelukast—chronic obstructive pulmonary disease	7e-05	0.000357	CcSEcCtD
Ofloxacin—Hypertension—Prednisolone—chronic obstructive pulmonary disease	6.89e-05	0.000351	CcSEcCtD
Ofloxacin—Bradycardia—Prednisone—chronic obstructive pulmonary disease	6.78e-05	0.000346	CcSEcCtD
Ofloxacin—Nausea—Salbutamol—chronic obstructive pulmonary disease	6.75e-05	0.000344	CcSEcCtD
Ofloxacin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	6.71e-05	0.000342	CcSEcCtD
Ofloxacin—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	6.7e-05	0.000341	CcSEcCtD
Ofloxacin—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	6.66e-05	0.00034	CcSEcCtD
Ofloxacin—Hallucination—Prednisone—chronic obstructive pulmonary disease	6.63e-05	0.000338	CcSEcCtD
Ofloxacin—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	6.55e-05	0.000334	CcSEcCtD
Ofloxacin—Oedema—Prednisolone—chronic obstructive pulmonary disease	6.52e-05	0.000332	CcSEcCtD
Ofloxacin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	6.52e-05	0.000332	CcSEcCtD
Ofloxacin—Shock—Prednisolone—chronic obstructive pulmonary disease	6.41e-05	0.000327	CcSEcCtD
Ofloxacin—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	6.36e-05	0.000324	CcSEcCtD
Ofloxacin—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	6.3e-05	0.000321	CcSEcCtD
Ofloxacin—Eye disorder—Prednisone—chronic obstructive pulmonary disease	6.23e-05	0.000317	CcSEcCtD
Ofloxacin—Flushing—Prednisone—chronic obstructive pulmonary disease	6.18e-05	0.000315	CcSEcCtD
Ofloxacin—Angiopathy—Prednisone—chronic obstructive pulmonary disease	6.05e-05	0.000308	CcSEcCtD
Ofloxacin—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	6.02e-05	0.000307	CcSEcCtD
Ofloxacin—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	5.95e-05	0.000303	CcSEcCtD
Ofloxacin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	5.89e-05	0.0003	CcSEcCtD
Ofloxacin—Alopecia—Prednisone—chronic obstructive pulmonary disease	5.89e-05	0.0003	CcSEcCtD
Ofloxacin—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	5.85e-05	0.000298	CcSEcCtD
Ofloxacin—Mental disorder—Prednisone—chronic obstructive pulmonary disease	5.84e-05	0.000298	CcSEcCtD
Ofloxacin—Erythema—Prednisone—chronic obstructive pulmonary disease	5.8e-05	0.000296	CcSEcCtD
Ofloxacin—Malnutrition—Prednisone—chronic obstructive pulmonary disease	5.8e-05	0.000296	CcSEcCtD
Ofloxacin—Pain—Prednisolone—chronic obstructive pulmonary disease	5.57e-05	0.000284	CcSEcCtD
Ofloxacin—Vision blurred—Prednisone—chronic obstructive pulmonary disease	5.47e-05	0.000279	CcSEcCtD
Ofloxacin—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	5.38e-05	0.000274	CcSEcCtD
Ofloxacin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	5.37e-05	0.000274	CcSEcCtD
Ofloxacin—Anaemia—Prednisone—chronic obstructive pulmonary disease	5.36e-05	0.000273	CcSEcCtD
Ofloxacin—Agitation—Prednisone—chronic obstructive pulmonary disease	5.33e-05	0.000272	CcSEcCtD
Ofloxacin—Angioedema—Prednisone—chronic obstructive pulmonary disease	5.3e-05	0.00027	CcSEcCtD
Ofloxacin—Malaise—Prednisone—chronic obstructive pulmonary disease	5.23e-05	0.000267	CcSEcCtD
Ofloxacin—Vertigo—Prednisone—chronic obstructive pulmonary disease	5.21e-05	0.000266	CcSEcCtD
Ofloxacin—Syncope—Prednisone—chronic obstructive pulmonary disease	5.2e-05	0.000265	CcSEcCtD
Ofloxacin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	5.18e-05	0.000264	CcSEcCtD
Ofloxacin—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	5.1e-05	0.00026	CcSEcCtD
Ofloxacin—Hypertension—Prednisone—chronic obstructive pulmonary disease	5.01e-05	0.000255	CcSEcCtD
Ofloxacin—Myalgia—Prednisone—chronic obstructive pulmonary disease	4.94e-05	0.000252	CcSEcCtD
Ofloxacin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	4.94e-05	0.000252	CcSEcCtD
Ofloxacin—Anxiety—Prednisone—chronic obstructive pulmonary disease	4.92e-05	0.000251	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	4.9e-05	0.00025	CcSEcCtD
Ofloxacin—Discomfort—Prednisone—chronic obstructive pulmonary disease	4.88e-05	0.000249	CcSEcCtD
Ofloxacin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	4.8e-05	0.000245	CcSEcCtD
Ofloxacin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	4.73e-05	0.000241	CcSEcCtD
Ofloxacin—Oedema—Prednisone—chronic obstructive pulmonary disease	4.73e-05	0.000241	CcSEcCtD
Ofloxacin—Infection—Prednisone—chronic obstructive pulmonary disease	4.7e-05	0.00024	CcSEcCtD
Ofloxacin—Shock—Prednisone—chronic obstructive pulmonary disease	4.66e-05	0.000237	CcSEcCtD
Ofloxacin—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	4.64e-05	0.000237	CcSEcCtD
Ofloxacin—Tachycardia—Prednisone—chronic obstructive pulmonary disease	4.62e-05	0.000236	CcSEcCtD
Ofloxacin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	4.6e-05	0.000234	CcSEcCtD
Ofloxacin—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	4.58e-05	0.000233	CcSEcCtD
Ofloxacin—Anorexia—Prednisone—chronic obstructive pulmonary disease	4.51e-05	0.00023	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	4.31e-05	0.00022	CcSEcCtD
Ofloxacin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	4.31e-05	0.00022	CcSEcCtD
Ofloxacin—Insomnia—Prednisone—chronic obstructive pulmonary disease	4.28e-05	0.000218	CcSEcCtD
Ofloxacin—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	4.25e-05	0.000217	CcSEcCtD
Ofloxacin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	4.17e-05	0.000212	CcSEcCtD
Ofloxacin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	4.12e-05	0.00021	CcSEcCtD
Ofloxacin—Rash—Prednisolone—chronic obstructive pulmonary disease	4.11e-05	0.000209	CcSEcCtD
Ofloxacin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	4.1e-05	0.000209	CcSEcCtD
Ofloxacin—Fatigue—Prednisone—chronic obstructive pulmonary disease	4.08e-05	0.000208	CcSEcCtD
Ofloxacin—Headache—Prednisolone—chronic obstructive pulmonary disease	4.08e-05	0.000208	CcSEcCtD
Ofloxacin—Constipation—Prednisone—chronic obstructive pulmonary disease	4.05e-05	0.000206	CcSEcCtD
Ofloxacin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	3.9e-05	0.000199	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	3.87e-05	0.000197	CcSEcCtD
Ofloxacin—Nausea—Prednisolone—chronic obstructive pulmonary disease	3.87e-05	0.000197	CcSEcCtD
Ofloxacin—Urticaria—Prednisone—chronic obstructive pulmonary disease	3.76e-05	0.000192	CcSEcCtD
Ofloxacin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	3.74e-05	0.000191	CcSEcCtD
Ofloxacin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	3.74e-05	0.000191	CcSEcCtD
Ofloxacin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	3.49e-05	0.000178	CcSEcCtD
Ofloxacin—Asthenia—Prednisone—chronic obstructive pulmonary disease	3.4e-05	0.000173	CcSEcCtD
Ofloxacin—Pruritus—Prednisone—chronic obstructive pulmonary disease	3.35e-05	0.000171	CcSEcCtD
Ofloxacin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	3.24e-05	0.000165	CcSEcCtD
Ofloxacin—Dizziness—Prednisone—chronic obstructive pulmonary disease	3.13e-05	0.00016	CcSEcCtD
Ofloxacin—Vomiting—Prednisone—chronic obstructive pulmonary disease	3.01e-05	0.000153	CcSEcCtD
Ofloxacin—Rash—Prednisone—chronic obstructive pulmonary disease	2.99e-05	0.000152	CcSEcCtD
Ofloxacin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	2.98e-05	0.000152	CcSEcCtD
Ofloxacin—Headache—Prednisone—chronic obstructive pulmonary disease	2.97e-05	0.000151	CcSEcCtD
Ofloxacin—Nausea—Prednisone—chronic obstructive pulmonary disease	2.81e-05	0.000143	CcSEcCtD
